Detalhe da pesquisa
1.
Participant characteristics and buprenorphine dose.
Am J Drug Alcohol Abuse
; 37(5): 453-9, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21854290
2.
Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy.
J Ethn Subst Abuse
; 9(2): 106-14, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20509084
3.
Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial.
Drug Alcohol Depend
; 128(1-2): 71-6, 2013 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22921476
4.
Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependence.
Addiction
; 107(2): 361-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22082089
5.
Buprenorphine tapering schedule and illicit opioid use.
Addiction
; 104(2): 256-65, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19149822